Jeffrey A Meckler Travere Therapeutics, Inc. (TVTX) insider trading activity

Jeffrey A Meckler is of Travere Therapeutics, Inc.. Currently has a direct ownership of 81,000 shares of TVTX, which is worth approximately $1.39 Million. The most recent transaction as insider was on Sep 30, 2024, when has been sold 40,000 shares (Common Stock) at a price of $14.06 per share, resulting in proceeds of $562,400. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 81K

0% 3M change

8.72% 12M change

Total Value Held $1.39 Million

Jeffrey A Meckler Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Sep 30 2024	SELL Open market or private sale	$562,400 $14.06 p/Share	40,000 Reduced 33.06%	81,000 Common Stock
Sep 30 2024	BUY Exercise of conversion of derivative security	$419,200 $10.48 p/Share	40,000 Added 24.84%	121,000 Common Stock
May 08 2024	BUY Grant, award, or other acquisition	-	6,500 Added 7.43%	81,000 Common Stock
May 17 2023	BUY Grant, award, or other acquisition	-	4,500 Added 5.7%	74,500 Common Stock
May 11 2022	BUY Grant, award, or other acquisition	-	3,000 Added 4.11%	70,000 Common Stock
May 14 2021	BUY Grant, award, or other acquisition	-	3,000 Added 4.29%	67,000 Common Stock

Also insider at

INDP

Indaptus Therapeutics, Inc. Healthcare

CEO and Director

JAM